Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: SOLARIS VACCINES, INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2025-07-02 to 2027-11-01
Current total value of award: $1298431.22
Description: DHA PHASE II SBIR CONTRACT FOR VACCIRAPTOR: HIGH-THROUGHPUT, CONTINUOUS FLOW-THROUGH SYSTEM FOR PSORALEN-UVA INACTIVATION